131
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Value of baseline platelet count for prediction of complications in primary biliary cirrhosis patients treated with ursodeoxycholic acid

, , , , , & show all
Pages 17-23 | Received 13 Feb 2012, Accepted 16 Sep 2012, Published online: 07 Jan 2013

References

  • Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261–73.
  • Prince M, Chetwynd A, Newman W, Metcalf JV, James OF. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;123:1044–51.
  • Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006; 130:715–20.
  • Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005;128:297–303.
  • Abe M, Onji M. Natural history of primary biliary cirrhosis. Hepatol Res 2008;38:639–45.
  • Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Lee PC, Lee SD, Wu JC. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int 2008;28:1305–13.
  • Wong RK, Lim SG, Wee A, Chan YH, Aung MO, Wai CT. Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population. J Gastroenterol Hepatol 2008;23:599–605.
  • Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1–7.
  • Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non- invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis 2003;35:473–8.
  • Pilette C, Oberti F, Aube C, Rousselet MC, Bedossa P, Gallois Y, Rifflet H, Cales P. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999;31:867–73.
  • Cardenas A, Gines P. Portal hypertension. Curr Opin Gastroenterol 2009;25:195–201.
  • Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 2008;40:267–74.
  • Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int 2006;26:666–72.
  • Alempijevic T, Krstic M, Jesic R, Jovanovic I, Sokic Milutinovic A, Kovacevic N, Krstic S, Popovic D. Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis. World J Gastroenterol 2009;15:591–4.
  • Nahon P, Ganne-Carrie N, Degos F, Nahon K, Paries J, Grando V, Chaffaut C, Njapoum C, Christidis C, Trinchet JC, Chevret S, Beaugrand M. Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis. Gastroenterol Clin Biol 2005;29:347–52.
  • Levy C, Zein CO, Gomez J, Soldevila-Pico C, Firpi R, Morelli G, Nelson D. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007;5:803–8.
  • Bressler B, Pinto R, El-Ashry D, Heathcote EJ. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?Gut 2005;54:407–10.
  • Plevris JN, Dhariwal A, Elton RA, Finlayson ND, Bouchier IA, Hayes PC. The platelet count as a predictor of variceal hemorrhage in primary biliary cirrhosis. Am J Gastroenterol 1995;90:959–61.
  • Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005–13.
  • Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores – where are we and where should we go?J Hepatol 2004;41:344–50.
  • Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 2007;26(Suppl. 1): 5–11.
  • Toshikuni N, Yamato R, Kobashi H, Nishino K, Inada N, Sakanoue R, Suehiro M, Fujimura Y, Yamada G. Association of primary biliary cirrhosis with idiopathic thrombocytopenic purpura. World J Gastroenterol 2008;14:2451–3.
  • Mizukami Y, Ohhira M, Matsumoto A, Murazumi Y, Murazumi K, Ohta H, Ono M, Miyake T, Maekawa I, Kohgo Y. Primary biliary cirrhosis associated with idiopathic thrombocytopenic purpura. J Gastroenterol 1996;31:284–8.
  • Takahashi T, Saitoh T, Imai K. Idiopathic thrombocytopenic purpura complicated with asymptomatic primary biliary cirrhosis. J Gastroenterol 2001;36:214–5.
  • Panzer S, Penner E, Nelson PJ, Prochazka E, Benda H, Saurugger PN. Identification of the platelet glycoprotein IIb/IIIa complex as a target antigen in primary biliary cirrhosis-associated autoimmune thrombocytopenia. Evidence that platelet-reactive autoantibodies can also bind to the mitochondrial antigen M2. J Autoimmun 1990;3:473–83.
  • Feistauer SM, Penner E, Mayr WR, Panzer S. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology 1997;25:1343–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.